Zeltiq Aesthetics (ZLTQ) 29.34 $ZLTQ
Zacks.com featured highlights: Antero Resources, ZELTIQ Aesthetics, Vertex Pharmaceuticals, ViaSat and Lumos Networks
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 8:30AM CDT
Zacks.com featured highlights: Antero Resources, ZELTIQ Aesthetics, Vertex Pharmaceuticals, ViaSat and Lumos Networks
VRTX: 88.96 (-1.09), AR: 25.70 (+0.24), ZLTQ: 29.34 (+0.58), LMOS: 12.56 (+0.11), VSAT: 73.64 (+2.62)
Dump These 5 Toxic Stocks to Avoid Portfolio Bleeding
Zacks Equity Research - Zacks Investment Research - Mon Jun 27, 8:22AM CDT
Investing in a stock whose current valuation exceeds its true inherent potential, is bound to result in loss over time.
AR: 25.70 (+0.24), VRTX: 88.96 (-1.09), ZLTQ: 29.34 (+0.58), LMOS: 12.56 (+0.11), VSAT: 73.64 (+2.62)
ZELTIQ(R) Announces Global Commercial Launch of the CoolAdvantage(TM) Applicator for the CoolSculpting(R) System
Marketwire Canada - Mon Jun 27, 8:01AM CDT
Innovative 3-in-1 Applicator Designed to Deliver Enhanced Patient Results
ZLTQ: 29.34 (+0.58)
Why Investors Love These Medical Appliances & Equipment's Stocks? - Align Technology, ZELTIQ Aesthetics, Amedica, and Nxstage Medical
PR Newswire - Wed Jun 22, 6:45AM CDT
Growth is expected for the U.S. Medical Appliances and Equipment industry as demand for healthcare continues to rise. In today's pre-market research, Stock-Callers.com shifts its attention on these four equities for investors' close review: Align Technology Inc. (NASDAQ: ALGN), ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ), Amedica Corp. (NASDAQ: AMDA), and Nxstage Medical Inc. (NASDAQ: NXTM). Learn more about these stocks and receive your complimentary trade alerts at:
NXTM: 22.91 (+1.07), ZLTQ: 29.34 (+0.58), ALGN: 82.93 (+1.04), AMDA: 0.88 (unch)
5 Toxic Stocks to Discard from Your Portfolio Right Now
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 7:27AM CDT
Identifying toxic stocks on a regular basis and removing them from one's portfolio is a secret to investing success.
VRTX: 88.96 (-1.09), ZLTQ: 29.34 (+0.58), ULTI: 215.80 (+1.35), LGF: 19.10 (+0.26), CRM: 80.89 (+2.13)
ZELTIQ Aesthetics, Inc. to Present at Two Upcoming Conferences
Marketwired - Tue May 31, 3:01PM CDT
PLEASANTON, CA --(Marketwired - May 31, 2016) - ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, and Taylor Harris, Senior Vice President and Chief Financial Officer, are scheduled to present at two upcoming conferences. The first presentation will be at the Goldman Sachs 37th Annual Global Healthcare Conference in Rancho Palos Verdes, CA.
ZLTQ: 29.34 (+0.58)
Zeltiq reports 1Q loss
Automated Insights - Tue May 10, 3:25PM CDT
PLEASANTON, Calif. (AP) _ Zeltiq Aesthetics Inc. (ZLTQ) on Tuesday reported a loss of $9.9 million in its first quarter.
ZLTQ: 29.34 (+0.58)
ZELTIQ Announces First Quarter 2016 Financial Results
Marketwire Canada - Tue May 10, 3:01PM CDT
Increases Revenue Guidance to a Range of $320 Million to $325 Million; Received FDA Clearance to Treat Fat Around Bra Straps, on the Back and Underneath the Buttocks; Launched CoolAdvantage(TM) Family of Applicators With 35 Minute Treatment Times; North America Account Utilization up 26% Year-over-Year
ZLTQ: 29.34 (+0.58)
NovaBay Pharmaceuticals Appoints Todd Zavodnick to its Board of Directors
BusinessWire - Mon May 09, 3:30PM CDT
NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its Avenova(R) lid and lash hygiene product for the domestic eye care market, announces the appointment of Todd Zavodnick to its Board of Directors, effective May 6, 2016. Mr. Zavodnick brings extensive senior management and commercial experience in the medical technology and pharmaceutical industries, including serving in a senior capacity at the global ophthalmology company Alcon Laboratories. Mr. Zavodnick will serve on the Audit and Nominating and Corporate Governance committees and replaces Massimo Radaelli, Ph.D., who resigned as a Director of NovaBay effective May 6, 2016. NovaBay's Board membership remains at eight.
ZLTQ: 29.34 (+0.58), NBY: 2.46 (+0.17)
Medical Stocks' Q1 Earnings Releases on May 10: ICUI, ZLTQ
Zacks Equity Research - Zacks Investment Research - Mon May 09, 9:44AM CDT
The two popular names in the medical space, gearing up to report results on May 10, are ICUI and ZLTQ.
ICUI: 115.00 (+1.34), ZLTQ: 29.34 (+0.58)
Hospira President, David J. Endicott, Joins ZELTIQ Aesthetics Board of Directors
Marketwired - Tue Apr 26, 8:04AM CDT
ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced David J. Endicott has joined its Board of Directors.
ZLTQ: 29.34 (+0.58)
Award-Winning CoolSculpting(R) Procedure Now FDA-Cleared to Reduce Fat Around Bra Straps, on the Back and Underneath the Buttocks
Marketwired - Tue Apr 05, 8:03AM CDT
ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced that it received an expanded clearance from the U.S. Food and Drug Administration (FDA) for the treatment of visible fat bulges of bra fat, back fat and underneath the buttocks (also known as banana roll). The CoolSculpting® procedure is already FDA-cleared for treatment of the double chin (submental area), thigh, abdomen and love handles (flank).
ZLTQ: 29.34 (+0.58)
ZELTIQ to Present at the 28th Annual ROTH Conference
Marketwired - Wed Mar 09, 3:01PM CST
ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer is scheduled to present at the 28th Annual ROTH Conference in Laguna Niguel, CA.
ZLTQ: 29.34 (+0.58)
ZELTIQ(R) Launches 3-in-1 CoolAdvantage(TM) Applicator for the CoolSculpting(R) System at American Academy of Dermatology Annual Meeting
Marketwired - Thu Mar 03, 8:02AM CST
ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced the launch of a new family of applicators called CoolAdvantage(TM) at the American Academy of Dermatology (AAD) Annual Meeting in Washington, D.C., March 4-8, 2016. The CoolAdvantage applicator delivers the proprietary CoolSculpting® cooling technology at a lower temperature, reducing treatment time nearly in half, and features an adaptable 3-in-1 configuration and enhanced cup design.
ZLTQ: 29.34 (+0.58)
Citizens Financial to join the S&P 500
M2 - Wed Feb 03, 7:40AM CST
S&P Dow Jones Indices has reported it will replace Precision Castparts Corp. (NYSE: PCP) with Citizens Financial Group Inc. (NYSE: CFG) in the S&P 500 after the close of trading on Friday, January 29, the company said. S&P 100 & 500 constituent Berkshire Hathaway Inc. (NYSE: BRK.
is acquiring Precision Castparts in a deal expected to be completed on or about that date pending final conditions. ZELTIQ Aesthetics Inc. (NASD:ZLTQ) will replace MedAssets Inc. (NASD:MDAS) in the S&P SmallCap 600 after the close of trading on Friday, January 29. Private equity firm Pamplona Capital Management is acquiring MedAssets in a deal expected to be completed soon pending final conditions. RE/MAX Holdings Inc. (NYSE: RMAX) will replace The Pep Boys--Manny, Moe & Jack (NYSE: PBY) in the S&P SmallCap 600 after the close of trading on Tuesday, February 2. Icahn Enterprises L.P. (NASD:IEP) is acquiring Pep Boys in a deal expected to be completed soon pending final conditions. Citizens Financial Group provides retail and commercial banking products and services. ZELTIQ Aesthetics is a medical technology company. RE/MAX Holdings operates as a franchisor of residential and commercial real estate brokerage services. S&P Dow Jones Indices LLC, a part of McGraw Hill Financial, is a resource for index-based concepts, data and research.
RMAX: 41.00 (+1.47), ZLTQ: 29.34 (+0.58), PBY: 18.50 (+0.01), CFG: 19.85 (+0.43), IEP: 53.99 (+1.32), MDAS: 31.35 (+0.01), MHFI: 107.92 (+1.16), BRK.B: 143.65 (+1.74), PCP: 234.95 (+0.10)
Medical Appliances & Equipment Equities Ahead of Market -- ResMed, ZELTIQ Aesthetics, MiMedx Group, and Varian Medical Systems
ACCESSWIRE - Wed Feb 03, 7:04AM CST
NEW YORK, NY / ACCESSWIRE / February 3, 2016 / Park Lane Advisor has initiated coverage on the following equities: ResMed Inc. (NYSE: RMD), ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ), MiMedx Group Inc. (NASDAQ: MDXG), and Varian Medical Systems Inc. (NYSE: VAR). Free research report on ResMed can be accessed at http://www.parklaneadvisor.com/ On Tuesday, February 02, 2016, the NASDAQ Composite ended at 4,516.95, down 2.24%, the Dow Jones Industrial Average declined 1.80%, to finish the day at 16,153.54, and the S&P 500 closed at 1,903.03, down 1.87%. Register for your complimentary reports at the links given below.
ZLTQ: 29.34 (+0.58), VAR: 84.99 (+1.17), RMD: 64.51 (+1.16), MDSY: 1.55 (unch), MDXG: 8.25 (+0.14)
ZELTIQ to Present at the Leerink Partners 5th Annual Global Healthcare Conference
Marketwired - Thu Jan 28, 3:01PM CST
ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer is scheduled to present at the Leerink Partners 5th Annual Global Healthcare Conference New York City.
ZLTQ: 29.34 (+0.58)
Zacks.com featured highlights: Antero Resources, ZELTIQ Aesthetics, Vertex Pharmaceuticals, ViaSat and Lumos Networks
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 8:30AM CDT
Zacks.com featured highlights: Antero Resources, ZELTIQ Aesthetics, Vertex Pharmaceuticals, ViaSat and Lumos Networks
VRTX: 88.96 (-1.09), AR: 25.70 (+0.24), ZLTQ: 29.34 (+0.58), LMOS: 12.56 (+0.11), VSAT: 73.64 (+2.62)
Dump These 5 Toxic Stocks to Avoid Portfolio Bleeding
Zacks Equity Research - Zacks Investment Research - Mon Jun 27, 8:22AM CDT
Investing in a stock whose current valuation exceeds its true inherent potential, is bound to result in loss over time.
AR: 25.70 (+0.24), VRTX: 88.96 (-1.09), ZLTQ: 29.34 (+0.58), LMOS: 12.56 (+0.11), VSAT: 73.64 (+2.62)
ZELTIQ(R) Announces Global Commercial Launch of the CoolAdvantage(TM) Applicator for the CoolSculpting(R) System
Marketwire Canada - Mon Jun 27, 8:01AM CDT
Innovative 3-in-1 Applicator Designed to Deliver Enhanced Patient Results
ZLTQ: 29.34 (+0.58)
Why Investors Love These Medical Appliances & Equipment's Stocks? - Align Technology, ZELTIQ Aesthetics, Amedica, and Nxstage Medical
PR Newswire - Wed Jun 22, 6:45AM CDT
Growth is expected for the U.S. Medical Appliances and Equipment industry as demand for healthcare continues to rise. In today's pre-market research, Stock-Callers.com shifts its attention on these four equities for investors' close review: Align Technology Inc. (NASDAQ: ALGN), ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ), Amedica Corp. (NASDAQ: AMDA), and Nxstage Medical Inc. (NASDAQ: NXTM). Learn more about these stocks and receive your complimentary trade alerts at:
NXTM: 22.91 (+1.07), ZLTQ: 29.34 (+0.58), ALGN: 82.93 (+1.04), AMDA: 0.88 (unch)
5 Toxic Stocks to Discard from Your Portfolio Right Now
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 7:27AM CDT
Identifying toxic stocks on a regular basis and removing them from one's portfolio is a secret to investing success.
VRTX: 88.96 (-1.09), ZLTQ: 29.34 (+0.58), ULTI: 215.80 (+1.35), LGF: 19.10 (+0.26), CRM: 80.89 (+2.13)
ZELTIQ Aesthetics, Inc. to Present at Two Upcoming Conferences
Marketwired - Tue May 31, 3:01PM CDT
PLEASANTON, CA --(Marketwired - May 31, 2016) - ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, and Taylor Harris, Senior Vice President and Chief Financial Officer, are scheduled to present at two upcoming conferences. The first presentation will be at the Goldman Sachs 37th Annual Global Healthcare Conference in Rancho Palos Verdes, CA.
ZLTQ: 29.34 (+0.58)
Zeltiq reports 1Q loss
Automated Insights - Tue May 10, 3:25PM CDT
PLEASANTON, Calif. (AP) _ Zeltiq Aesthetics Inc. (ZLTQ) on Tuesday reported a loss of $9.9 million in its first quarter.
ZLTQ: 29.34 (+0.58)
ZELTIQ Announces First Quarter 2016 Financial Results
Marketwire Canada - Tue May 10, 3:01PM CDT
Increases Revenue Guidance to a Range of $320 Million to $325 Million; Received FDA Clearance to Treat Fat Around Bra Straps, on the Back and Underneath the Buttocks; Launched CoolAdvantage(TM) Family of Applicators With 35 Minute Treatment Times; North America Account Utilization up 26% Year-over-Year
ZLTQ: 29.34 (+0.58)
NovaBay Pharmaceuticals Appoints Todd Zavodnick to its Board of Directors
BusinessWire - Mon May 09, 3:30PM CDT
NovaBay(R) Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its Avenova(R) lid and lash hygiene product for the domestic eye care market, announces the appointment of Todd Zavodnick to its Board of Directors, effective May 6, 2016. Mr. Zavodnick brings extensive senior management and commercial experience in the medical technology and pharmaceutical industries, including serving in a senior capacity at the global ophthalmology company Alcon Laboratories. Mr. Zavodnick will serve on the Audit and Nominating and Corporate Governance committees and replaces Massimo Radaelli, Ph.D., who resigned as a Director of NovaBay effective May 6, 2016. NovaBay's Board membership remains at eight.
ZLTQ: 29.34 (+0.58), NBY: 2.46 (+0.17)
Medical Stocks' Q1 Earnings Releases on May 10: ICUI, ZLTQ
Zacks Equity Research - Zacks Investment Research - Mon May 09, 9:44AM CDT
The two popular names in the medical space, gearing up to report results on May 10, are ICUI and ZLTQ.
ICUI: 115.00 (+1.34), ZLTQ: 29.34 (+0.58)
Hospira President, David J. Endicott, Joins ZELTIQ Aesthetics Board of Directors
Marketwired - Tue Apr 26, 8:04AM CDT
ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced David J. Endicott has joined its Board of Directors.
ZLTQ: 29.34 (+0.58)
Award-Winning CoolSculpting(R) Procedure Now FDA-Cleared to Reduce Fat Around Bra Straps, on the Back and Underneath the Buttocks
Marketwired - Tue Apr 05, 8:03AM CDT
ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced that it received an expanded clearance from the U.S. Food and Drug Administration (FDA) for the treatment of visible fat bulges of bra fat, back fat and underneath the buttocks (also known as banana roll). The CoolSculpting® procedure is already FDA-cleared for treatment of the double chin (submental area), thigh, abdomen and love handles (flank).
ZLTQ: 29.34 (+0.58)
ZELTIQ to Present at the 28th Annual ROTH Conference
Marketwired - Wed Mar 09, 3:01PM CST
ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer is scheduled to present at the 28th Annual ROTH Conference in Laguna Niguel, CA.
ZLTQ: 29.34 (+0.58)
ZELTIQ(R) Launches 3-in-1 CoolAdvantage(TM) Applicator for the CoolSculpting(R) System at American Academy of Dermatology Annual Meeting
Marketwired - Thu Mar 03, 8:02AM CST
ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced the launch of a new family of applicators called CoolAdvantage(TM) at the American Academy of Dermatology (AAD) Annual Meeting in Washington, D.C., March 4-8, 2016. The CoolAdvantage applicator delivers the proprietary CoolSculpting® cooling technology at a lower temperature, reducing treatment time nearly in half, and features an adaptable 3-in-1 configuration and enhanced cup design.
ZLTQ: 29.34 (+0.58)
Citizens Financial to join the S&P 500
M2 - Wed Feb 03, 7:40AM CST
S&P Dow Jones Indices has reported it will replace Precision Castparts Corp. (NYSE: PCP) with Citizens Financial Group Inc. (NYSE: CFG) in the S&P 500 after the close of trading on Friday, January 29, the company said. S&P 100 & 500 constituent Berkshire Hathaway Inc. (NYSE: BRK.
is acquiring Precision Castparts in a deal expected to be completed on or about that date pending final conditions. ZELTIQ Aesthetics Inc. (NASD:ZLTQ) will replace MedAssets Inc. (NASD:MDAS) in the S&P SmallCap 600 after the close of trading on Friday, January 29. Private equity firm Pamplona Capital Management is acquiring MedAssets in a deal expected to be completed soon pending final conditions. RE/MAX Holdings Inc. (NYSE: RMAX) will replace The Pep Boys--Manny, Moe & Jack (NYSE: PBY) in the S&P SmallCap 600 after the close of trading on Tuesday, February 2. Icahn Enterprises L.P. (NASD:IEP) is acquiring Pep Boys in a deal expected to be completed soon pending final conditions. Citizens Financial Group provides retail and commercial banking products and services. ZELTIQ Aesthetics is a medical technology company. RE/MAX Holdings operates as a franchisor of residential and commercial real estate brokerage services. S&P Dow Jones Indices LLC, a part of McGraw Hill Financial, is a resource for index-based concepts, data and research. RMAX: 41.00 (+1.47), ZLTQ: 29.34 (+0.58), PBY: 18.50 (+0.01), CFG: 19.85 (+0.43), IEP: 53.99 (+1.32), MDAS: 31.35 (+0.01), MHFI: 107.92 (+1.16), BRK.B: 143.65 (+1.74), PCP: 234.95 (+0.10)
Medical Appliances & Equipment Equities Ahead of Market -- ResMed, ZELTIQ Aesthetics, MiMedx Group, and Varian Medical Systems
ACCESSWIRE - Wed Feb 03, 7:04AM CST
NEW YORK, NY / ACCESSWIRE / February 3, 2016 / Park Lane Advisor has initiated coverage on the following equities: ResMed Inc. (NYSE: RMD), ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ), MiMedx Group Inc. (NASDAQ: MDXG), and Varian Medical Systems Inc. (NYSE: VAR). Free research report on ResMed can be accessed at http://www.parklaneadvisor.com/ On Tuesday, February 02, 2016, the NASDAQ Composite ended at 4,516.95, down 2.24%, the Dow Jones Industrial Average declined 1.80%, to finish the day at 16,153.54, and the S&P 500 closed at 1,903.03, down 1.87%. Register for your complimentary reports at the links given below.
ZLTQ: 29.34 (+0.58), VAR: 84.99 (+1.17), RMD: 64.51 (+1.16), MDSY: 1.55 (unch), MDXG: 8.25 (+0.14)
ZELTIQ to Present at the Leerink Partners 5th Annual Global Healthcare Conference
Marketwired - Thu Jan 28, 3:01PM CST
ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer is scheduled to present at the Leerink Partners 5th Annual Global Healthcare Conference New York City.
ZLTQ: 29.34 (+0.58)
